Additionally, germline SGMS2 variants are associated with early-onset osteoporosis and skeletal dysplasia with bone fragility, highlighting the role of plasma-membrane sphingomyelin metabolism in osteoblast/osteocyte biology [53]. This evidence concerns the gene SGMS2 and osteoporosis.